JP2016507520A5 - - Google Patents

Download PDF

Info

Publication number
JP2016507520A5
JP2016507520A5 JP2015555242A JP2015555242A JP2016507520A5 JP 2016507520 A5 JP2016507520 A5 JP 2016507520A5 JP 2015555242 A JP2015555242 A JP 2015555242A JP 2015555242 A JP2015555242 A JP 2015555242A JP 2016507520 A5 JP2016507520 A5 JP 2016507520A5
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
hbc
seq
vlp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015555242A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016507520A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/012586 external-priority patent/WO2014116730A2/en
Publication of JP2016507520A publication Critical patent/JP2016507520A/ja
Publication of JP2016507520A5 publication Critical patent/JP2016507520A5/ja
Pending legal-status Critical Current

Links

JP2015555242A 2013-01-23 2014-01-22 安定化されたb型肝炎コアポリペプチド Pending JP2016507520A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361755850P 2013-01-23 2013-01-23
US61/755,850 2013-01-23
US201361901243P 2013-11-07 2013-11-07
US61/901,243 2013-11-07
PCT/US2014/012586 WO2014116730A2 (en) 2013-01-23 2014-01-22 Stabilized hepatitis b core polypeptide

Publications (2)

Publication Number Publication Date
JP2016507520A JP2016507520A (ja) 2016-03-10
JP2016507520A5 true JP2016507520A5 (enExample) 2017-03-30

Family

ID=51228185

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015555242A Pending JP2016507520A (ja) 2013-01-23 2014-01-22 安定化されたb型肝炎コアポリペプチド

Country Status (5)

Country Link
US (1) US9896483B2 (enExample)
EP (1) EP2948469A4 (enExample)
JP (1) JP2016507520A (enExample)
CA (1) CA2936092A1 (enExample)
WO (1) WO2014116730A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016507520A (ja) 2013-01-23 2016-03-10 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 安定化されたb型肝炎コアポリペプチド
AU2016207099C1 (en) * 2015-01-15 2021-02-04 University Of Copenhagen Virus-like particle with efficient epitope display
WO2017071713A1 (en) 2015-10-30 2017-05-04 University Of Copenhagen Virus like particle with efficient epitope display
CN106636016B (zh) * 2017-02-24 2020-03-17 天津大学 一种通过正负电荷引入辅助病毒样颗粒自组装的方法和应用
US11931406B2 (en) * 2017-12-13 2024-03-19 CureVac SE Flavivirus vaccine
WO2020139843A1 (en) * 2018-12-28 2020-07-02 The Board Of Trustee Of The Leland Stanford Junior University Engineered hepatitis b core polypeptide
CN109666067A (zh) * 2019-01-07 2019-04-23 中国科学院过程工程研究所 一种重组病毒样颗粒及其制备方法和用途
CN113939527B (zh) * 2019-01-11 2025-10-28 新加坡科技研究局 Hla-a*11:01限制性乙型肝炎病毒(hbv)肽用于鉴别hbv特异性cd8+ t细胞的用途

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5361794A (en) 1992-10-14 1994-05-09 Board Of Trustees Of The Leland Stanford Junior University Enhancement of b cell lymphoma tumor resistance using idiotype/cytokine conjugates
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
AU713040B2 (en) 1994-07-15 1999-11-18 University Of Iowa Research Foundation, The Immunomodulatory oligonucleotides
US5968767A (en) 1996-06-07 1999-10-19 Genentech, Inc. Methods for in vitro protein synthesis
US6593103B1 (en) 1997-02-07 2003-07-15 The Regents Of The University Of California HIV capsid assembly-associated compositions and method
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
WO1998055609A1 (en) 1997-06-06 1998-12-10 The Regents Of The University Of California Inhibitors of dna immunostimulatory sequence activity
JP4480268B2 (ja) * 1998-02-12 2010-06-16 イミューン コンプレックス コーポレイション 戦略的修飾されたb型肝炎コアタンパク質及びそれらの誘導体
WO2000023955A1 (en) 1998-10-21 2000-04-27 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Virus-like particles for the induction of autoantibodies
DK1135408T3 (da) * 1998-12-04 2012-01-23 Biogen Idec Inc HBV-kerneantigenpartikler med multipelle immunogene komponenter, som er bundne via peptidligander
US6168931B1 (en) 1999-03-17 2001-01-02 The Board Of Trustees Of The Leland Stanford Junior University Enhanced in vitro synthesis of biological macromolecules using a novel ATP regeneration system
US6994986B2 (en) 1999-03-17 2006-02-07 The Board Of Trustees Of The Leland Stanford University In vitro synthesis of polypeptides by optimizing amino acid metabolism
US6337191B1 (en) 1999-03-22 2002-01-08 The Board Of Trustees Of The Leland Stanford Junior University Vitro protein synthesis using glycolytic intermediates as an energy source
US6586207B2 (en) 2000-05-26 2003-07-01 California Institute Of Technology Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
US7041479B2 (en) 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
US6548276B2 (en) 2000-09-06 2003-04-15 The Board Of Trustees Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
ES2464532T3 (es) 2001-04-19 2014-06-03 The Scripps Research Institute Métodos y composiciones para la producción de pares ortogonales de ARNt-aminoacil-ARNt sintetasa
EP1450856B1 (en) 2001-09-14 2009-11-11 Cytos Biotechnology AG Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
AU2002366710A1 (en) 2001-12-20 2003-07-09 The Government Of The United States Of America As Represented By The Secretary Of The Department Of USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
US8466116B2 (en) 2001-12-20 2013-06-18 The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce epithelial cell growth
US7375234B2 (en) 2002-05-30 2008-05-20 The Scripps Research Institute Copper-catalysed ligation of azides and acetylenes
PT1539948E (pt) 2002-08-19 2010-01-20 Univ Leland Stanford Junior Métodos melhorados para a síntese de proteínas in vitro
US7713532B2 (en) * 2002-09-06 2010-05-11 Advanced Life Science Institute, Inc. HBV precore protein capable of forming particles
US20060240024A1 (en) 2003-02-28 2006-10-26 The Johns Hopkins University T cell regulation
CN101675993A (zh) 2003-03-26 2010-03-24 赛托斯生物技术公司 Melan-a肽类似物-病毒样颗粒偶联物
JP5275566B2 (ja) 2003-06-18 2013-08-28 ザ スクリプス リサーチ インスティチュート 反応性非天然アミノ酸遺伝コード付加
WO2005005614A2 (en) * 2003-07-03 2005-01-20 Pecos Labs, Inc. Combined b-cell and t-cell epitopes on vlp for improved vaccines
US7341852B2 (en) 2003-07-18 2008-03-11 The Board Of Trustees Of The Leland Stanford Junior University Methods of decoupling reaction scale and protein synthesis yield in batch mode
US20050054044A1 (en) 2003-07-18 2005-03-10 The Board Of Trustees Of The Leland Stanford Junior University Method of alleviating nucleotide limitations for in vitro protein synthesis
CA2541360A1 (en) 2003-10-08 2005-04-21 Bradley T. Messmer Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
CN101014716B (zh) 2003-11-20 2015-06-10 小利兰·斯坦福大学托管委员会 体外蛋白质合成的改进方法
US20050170551A1 (en) 2004-02-04 2005-08-04 Strip David R. Manufacture of flat panel light emitting devices
US7964196B2 (en) * 2004-05-25 2011-06-21 Chimeros, Inc. Self-assembling nanoparticle drug delivery system
MX2007003142A (es) 2004-09-21 2007-07-04 Scripps Research Inst Incorporacion in vivo de alquinil aminoacidos a proteinas en eubacterias.
WO2006065751A2 (en) 2004-12-13 2006-06-22 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Cpg oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
JP2009533350A (ja) * 2006-04-07 2009-09-17 キメロス, インコーポレイテッド B細胞悪性疾患を処置するための組成物および方法
US20080096819A1 (en) 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
US20110129438A1 (en) 2006-06-28 2011-06-02 James Robert Swartz Immunogenic protein constructs
DK2035554T3 (da) 2006-06-29 2013-06-17 Univ Leland Stanford Junior Celle-fri syntese af proteiner indeholdende ikke-naturlige aminosyrer
US20090317861A1 (en) 2006-06-29 2009-12-24 Bundy Bradley C Cell-free synthesis of virus like particles
CN101511856B (zh) 2006-09-08 2016-01-20 Ambrx公司 脊椎动物细胞中抑制因子trna的转录
CA2673765A1 (en) 2007-01-18 2008-07-24 The Board Of Trustees Of The Leland Stanford Junior University Enhanced cell-free synthesis of active proteins containing disulfide bonds
CA2707840A1 (en) 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
US8445706B2 (en) 2008-09-05 2013-05-21 Board Of Trustees Of Northern Illinois University Unnatural amino acids capable of covalently modifying protein phosphatases and their use as general and specific inhibitors and probes
WO2010042755A2 (en) * 2008-10-08 2010-04-15 Chimeros Inc. Chimeric therapeutics, compositions, and methods for using same
US20100168402A1 (en) 2008-11-14 2010-07-01 Bundy Bradley C Direct Attachment of Polypeptides to Virus Like Particles
US8324149B2 (en) 2008-11-18 2012-12-04 The Board Of Trustees Of The Leland Stanford Junior University Encapsidation of heterologous entities into virus-like particles
DE112010006063B4 (de) 2009-11-05 2018-12-27 Novici Biotech Llc Erzeugung von Antigenen, virusartigen Partikeln über Protein-Protein-Bindungen
US8685416B2 (en) 2010-03-02 2014-04-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compositions and methods for the treatment of cancer
CA2847888A1 (en) * 2011-09-09 2013-03-14 Biomed Realty, L.P. Methods and compositions for controlling assembly of viral proteins
EP2809345A4 (en) 2012-02-03 2015-11-25 Univ Emory IMMUNOSTIMULATING COMPOSITIONS, PARTICLES THEREFOR, AND USES THEREFOR
JP2016507520A (ja) 2013-01-23 2016-03-10 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 安定化されたb型肝炎コアポリペプチド
JP2016515538A (ja) 2013-03-15 2016-05-30 ブレット バイオテクノロジー、 インク.Bullet Biotechnology, Inc. 特異的な多価ウイルス様粒子ワクチンおよびその使用
US20170035864A1 (en) 2013-12-09 2017-02-09 Bullet Biotechnology, Inc. SPECIFIC VIRUS-LIKE PARTICLE-CpG OLIGONUCLEOTIDE VACCINES AND USES THEREOF

Similar Documents

Publication Publication Date Title
JP2015531407A5 (enExample)
JP2012095652A5 (enExample)
JP2005120106A5 (enExample)
RU2012122173A (ru) Варианты альбумина
RU2010108308A (ru) Способ получения гетерогенных белков
ZA202100386B (en) Influenza virus hemagglutinin mutants
JP2019530466A5 (enExample)
JP2014221052A5 (enExample)
DK1885850T3 (da) Fremgangsmåde til fremstilling af D-psicose ved D-psicose-epimerase
RU2011128371A (ru) Модифицированные f протеины sv и способы их применения
JP2016526909A5 (enExample)
JP2007197439A5 (enExample)
JP2020528760A (ja) 新規融合タンパク質の調製およびそのタンパク質合成の向上における使用
JP2007513634A5 (enExample)
JP2014524241A5 (enExample)
JP2011152137A5 (enExample)
CA2567254A1 (en) Tc-83-derived alphavirus vectors, particles and methods
JP2009268467A5 (enExample)
MY197457A (en) Chimeric papillomavirus l1 protein
RU2019139064A (ru) Композиции и способы для лечения цитомегаловируса
WO2006119516A3 (en) Expression of viral proteins in plants
JP2014076042A5 (enExample)
RU2018113521A (ru) Рекомбинантный полипептид гемагглютинин (ha) вируса гриппа для вызова иммунного ответа в отношении вирусов гриппа h2n2 или b
CN104031118B (zh) 鼠多瘤病毒衣壳粒的新型亲和肽配基及其设计筛选方法
PH12021550898A1 (en) Virus-like particles of cmv modified by fusion